Continent Country Year Patient source Genotype (synonyms)/
isolates Reference Peru 2003 HIV+ A (Peru1)/82, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/41, Peru3/2, [56 ] America Peru 2000–2002 HIV+ A (Peru1)/35, Peru3/1, Peru7/8, Peru8/4, Peru11 (Peru12)/ 6, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/9, EbpC (E, WL13, Peru4, WL17)/1, Peru10/3, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/ 18, WL11(Peru5)/3, Peru6 (PtEb I, PtEb VII)/1. [48 ] Peru 2007 Children apparently immunocompetent A (Peru1), Type IV (K, Peru2), Peru3, EbpC (Peru4), WL11(Peru5), Peru6 (PtEb I, PtEb VII), Peru7, Peru8, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc), Peru10, Peru11 (Peru12), Peru13, WL15 (Peru14), Peru15, Peru16, Peru17 [75 ] Portugal 1999- 2009 HIV+, HIV−; Adults and children Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/18, Peru6 (PtEb I, PtEb VII)/14, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/6, A (Peru1)/4, C (Type II)/3, PtEb II/3. [45 ] Spain 2009 HIV−; renal transplant recipients D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/2 [108 ] France 1998 HIV+; immunocompromised HIV− B (Type I)/51 HIV+, C (Type II)/6 HIV+, 2 HIV–, Type III/3 HIV+, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/3 HIV+ [109 ] France 2001 HIV+; HIV− B (Type I)/66 HIV+, C (Type II)/9 HIV+, 8 immunocompromised HIV–, and 1 immunocompetent ), Type III/3 HIV+, [92 ] Germany 1993 HIV+ A(Peru1)/3, B (Type I)/3, C (Type II)/2 [94 ] Europe Germany 2001 Human patients C (Type II)/1, Q/1 [95 ] Switzerland 2000 Human patients Q [110 ] UK 1992–1995; 2002 HIV+ B (Type I)/11, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/1, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/1 [111 ] The Netherlands 1996–2007 A(Peru1)/1, B (Type I)/4, C (Type II)/5, S7/1, S8/1, S9/1, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/2, Type IV (K)/5, [112 ] Czech Republic 2008-2009 HIV− EbpA/10, CZ3/4, PigEBITS5/3, BFRmr2/2, BEB4/2, CZ1/1, CZ2/1 [20 ] Russia HIV+ patients D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/2 [87 ] Niger 2007 HIV+ (227 adults, 1 child) A (Peru1)/10, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/1, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/1, CAF1 (PEbE)/2, NIA1/3 [76 ] Nigeria 2011 Children with and without diarrhea D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/2, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/1, new genotype (similar to genotype K (with two nucleotide substitutions)/1 [67 ] Nigeria 2012 HIV+ B/1, new genotype (similar to P, Type IV, UG2145; Peru3, PtEb IV, PtEb V)/2 [68 ] Africa Cameroon 2006 HIV+ Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/4 [55 ] Cameroon 2007 Villagers <1 to 80 years; 0.5% (4/758) HIV+ A (Peru1)/8, B (Type I)/3, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/3, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/1, CAF4/5 [99 ] Gabon 2007 HIV+ > 16 years A (Peru1)/1, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/1, TypeIV (K)/4, CAF1 (PEbE)/3, CAF2/1, CAF3/1, CAF4/4 [99 ] Uganda 2002 Children (immune status not determined) Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/6, UG2145/1 [18 ] Malawi 2003-2004 Peru8/1, UG2145/1, S1/2, S2/11, S3/2, S4/1, S5/4, S6/2, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/4, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/8 [112 ] Asia China 2011 Children with diarrhea I (BEB2, CEbE)/3, J (BEB1,CEbB, PtEb X)/3, CHN1/5, CHN2/2, CHN3/4, CHN4/3 [30 ] Thailand 2005 HIV+ and HIV− children from an orphanage A (Peru1)/10. [5 ] Thailand 2006 HIV+ (33 adults) D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/12, EbpC (E, WL13, Peru4, WL17)/5, O/1, R/1, S/4, T/1, U/1, V/1, W/1, Peru 11 (Peru12)/2, PigEBITS7/4. [113 ] Thailand 2005 Asymptomatic adults (5) and children (2) A (Peru1)/7 [114 ] Thailand 2005 D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/5 [102 ] Thailand 2003-2004 HIV+ and HIV− children from an orphanage A (Peru1)/75 [19 ] Vietnam 2007 HIV+ D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/1, EbpC (E, WL13, Peru4, WL17)/1, HAN1/1 [76 ] Oceania Australia 2005–2007 HIV+ (men) with diarrhea; CD4+ T-cell counts < 100 cells mm−3 B (Type I)/29 [115 ]
